We know NIV works well for patients with acute COPD or acute CHF exacerbations. In this episode we discuss the evidence for NIV not only in COPD and CHF, but also a myriad of other conditions. Do you know what the latest guidelines say on NIV for asthma, immunocompromised patients, or undifferentiated acute respiratory failure? Take a listen!
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published. In addition to its use in...
More than 200,000 patients per year undergo coronary artery bypass graft (CABG) surgery. Up to 20 percent of these patients will require readmission within...
Both etomidate and propofol are commonly used sedative agents in critically ill patients. Recent literature has suggested that these agents may result in increased...